Rising Biosciences (RBII) Stock Statistics & Valuation Metrics
Total Valuation
Rising Biosciences has a market cap or net worth of $1,060.00. The enterprise value is $2.28T.
- Market Cap
- $1,060.00
- Enterprise Value
- $2.28T
Share Statistics
Rising Biosciences has 1,059,725,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,059,725,300
- Owned by Insiders
- ―
- Owned by Institutions
- 0.00%
Financial Efficiency
Rising Biosciences’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -851.75%.
- Return on Equity (ROE)
- -0.05
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- -851.75%
- Return on Capital Employed (ROCE)
- -0.26
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 1.22
- Inventory Turnover
- 8.45
Income Statement
In the last 12 months, Rising Biosciences had revenue of 782.28K and earned 49.76K in profits. Earnings per share was 0.00.
- Revenue
- 782.28K
- Gross Profit
- 448.38K
- Operating Income
- 284.17K
- Pretax Income
- 49.76K
- Net Income
- 49.76K
- EBITDA
- 152.69K
- Earnings Per Share (EPS)
- 0.00
Stock Price Statistics
- Beta
- 21.86
- 52-Week Price Change
- -99.99%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Rising Biosciences as a current ratio of 0.12, with Debt / Equity ratio of -96.94%
- Current Ratio
- 0.12
- Quick Ratio
- 0.10
- Debt to Market Cap
- 0.83
- Net Debt to EBITDA
- 6.60
- Interest Coverage Ratio
- 4.09
Taxes
In the past 12 months, Rising Biosciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Analyst Forecast
The average price target for Rising Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
